QIAGEN N.V. (QGEN)

Price$36.68

Value ScoreC

Growth ScoreC

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-31.11%

Price vs S&P 500 (4W)11.03%

VGM Score49.34

Market Capitalization$7.56B

P/E Ratio (Annual)17.79x

Indicated Dividend Yield (Annual)0.70%

All Metrics

P/CF (Annual)11.55x

Book Value / Share (Quarterly)$16.15

P/TBV (Annual)2.88x

Indicated Dividend (Annual)$0.35

Revenue Growth (3Y)-0.81%

Cash Flow / Share (Quarterly)$1.96

Price vs S&P 500 (YTD)-26.59%

Gross Margin (TTM)62.59%

Net Profit Margin (TTM)19.16%

EPS (TTM)$1.89

10-Day Avg Trading Volume2.21M

EPS Excl Extra (TTM)$1.89

Revenue Growth (5Y)2.25%

EPS (Annual)$1.94

Dividend / Share (Annual)$0.25

ROI (Annual)7.82%

Gross Margin (Annual)63.67%

Net Profit Margin (5Y Avg)16.89%

Cash / Share (Quarterly)$3.13

P/E Basic Excl Extra (TTM)18.80x

Revenue Growth QoQ (YoY)1.83%

EPS Growth (5Y)4.22%

P/E Normalized (Annual)17.79x

ROA (Last FY)6.76%

Revenue Growth TTM (YoY)4.79%

EBITD / Share (TTM)$2.08

ROE (5Y Avg)10.26%

Operating Margin (TTM)20.72%

Cash Flow / Share (Annual)$2.06

P/B Ratio2.27x

P/B Ratio (Quarterly)2.48x

Net Income / Employee (Annual)$75,100

EV / Revenue (TTM)4.08x

Net Interest Coverage (TTM)27.84x

ROA (TTM)6.58%

EPS Growth QoQ (YoY)-24.94%

EV / EBITDA (TTM)19.30x

EPS Incl Extra (Annual)$1.94

Current Ratio (Annual)3.90x

Quick Ratio (Quarterly)2.18x

3-Month Avg Trading Volume2.14M

52-Week Price Return-19.49%

EV / Free Cash Flow (Annual)19.14x

P/E Incl Extra (TTM)18.80x

Revenue / Employee (TTM)$371,200

Tangible BV / Share (Quarterly)$14.37

P/S Ratio (Annual)3.62x

Asset Turnover (Annual)0.33x

52-Week High$57.81

Operating Margin (5Y Avg)20.11%

EPS Excl Extra (Annual)$1.94

CapEx CAGR (5Y)-7.40%

Tangible BV CAGR (5Y)10.36%

26-Week Price Return-23.18%

Quick Ratio (Annual)3.21x

13-Week Price Return-21.02%

Total Debt / Equity (Annual)0.44x

Current Ratio (Quarterly)3.21x

Enterprise Value$8.56B

Revenue / Share Growth (5Y)3.04%

Asset Turnover (TTM)0.34x

Book Value / Share Growth (5Y)6.64%

Revenue / Employee (Annual)$369,600

Inventory Turnover (Annual)2.61x

Pretax Margin (Annual)23.46%

Cash / Share (Annual)$5.07

3-Month Return Std Dev36.01%

Gross Margin (5Y Avg)63.87%

Net Income / Employee (TTM)$71,100

EBITDA CAGR (5Y)2.97%

EBITDA Interim CAGR (5Y)-12.51%

ROE (Last FY)11.25%

Net Interest Coverage (Annual)176.52x

EPS Basic Excl Extra (Annual)$1.94

P/FCF (TTM)18.72x

Receivables Turnover (TTM)5.60x

EV / Free Cash Flow (TTM)21.19x

Total Debt / Equity (Quarterly)0.49x

EPS Incl Extra (TTM)$1.89

Receivables Turnover (Annual)5.38x

ROI (TTM)7.61%

P/S Ratio (TTM)3.60x

Pretax Margin (5Y Avg)20.64%

Revenue / Share (Annual)$9.56

Tangible BV / Share (Annual)$15.66

Forward P/E15.09x

Free OCF CAGR (5Y)23.83%

Price vs S&P 500 (52W)-43.86%

P/E Ratio (TTM)18.80x

EPS Growth TTM (YoY)341.35%

Year-to-Date Return-18.43%

5-Day Price Return1.38%

EPS Normalized (Annual)$1.94

ROA (5Y Avg)5.78%

Net Profit Margin (Annual)20.33%

Month-to-Date Return0.25%

Cash Flow / Share (TTM)$2.35

EBITD / Share (Annual)$2.16

EPS Growth (3Y)0.85%

Operating Margin (Annual)22.17%

LT Debt / Equity (Annual)0.44x

P/CF (TTM)12.29x

ROI (5Y Avg)6.81%

P/E Excl Extra (TTM)18.80x

LT Debt / Equity (Quarterly)0.49x

EPS Basic Excl Extra (TTM)$1.89

P/TBV (Quarterly)2.79x

Payout Ratio (Annual)12.77%

P/B Ratio (Annual)2.58x

Inventory Turnover (TTM)2.66x

Pretax Margin (TTM)21.75%

Book Value / Share (Annual)$17.45

Price vs S&P 500 (13W)-29.27%

Net Margin Growth (5Y)1.15%

Beta0.65x

P/FCF (Annual)16.90x

Revenue / Share (TTM)$10.05

ROE (TTM)11.28%

52-Week Low$32.53

vGradeC

gGradeC

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.54est. 0.55

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.58

3.63

3.67

Industry Peers — Biological Products(178)

Symbol	Value Score	Growth Score	Momentum Score	Price
QGENQIAGEN N.V.	C	C	C	$36.68
AMGNAmgen Inc	C	C	C	$349.58
GILDGilead Sciences Inc	C	B	C	$129.16
ARGXargenx SE American Depositary Shares	D	A	B	$891.32
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$149.23
BIIBBiogen Inc. Common Stock	B	D	B	$195.34
BNTXBioNTech SE American Depositary Share	C	C	D	$88.08
MRNAModerna, Inc. Common Stock	C	B	B	$47.44
NBIXNeurocrine Biosciences Inc	C	B	B	$163.88
EXELExelixis Inc	C	B	B	$52.70
KRYSKrystal Biotech, Inc. Common Stock	D	B	A	$301.00

About

Qiagen develops proprietary sample preparation and diagnostic solutions serving life sciences research and molecular diagnostics equally. The business model generates roughly 90% of revenue from consumables, with the remainder from instruments and services. North America represents the largest market (52% of 2024 sales), followed by EMEA (33%) and Asia-Pacific (15%).